Chemours (CC) Operating Income (2014 - 2026)

Chemours has reported Operating Income for 13 years, with the latest figure at $26.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Income fell 50.94% year-over-year to $26.0 million; the trailing twelve-month figure through Mar 2026 stood at -$90.0 million (down 134.88% YoY), and the FY2025 full-year result was -$58.0 million, down 363.64% from the prior year.
• Operating Income for Q1 2026 stood at $26.0 million, up from -$5.0 million in the prior quarter.
• The five-year high for Operating Income was $304.0 million in Q1 2022, with the low at -$396.0 million in Q2 2023.
• Average Operating Income over 5 years is $47.6 million, with a median of $53.0 million recorded in 2025.
• Year-over-year, Operating Income tumbled 282.49% in 2023 and soared 1116.67% in 2024.
• Tracing CC's Operating Income over 5 years: stood at -$9.0 million in 2022, then soared by 33.33% to -$6.0 million in 2023, then soared by 1116.67% to $61.0 million in 2024, then plunged by 108.2% to -$5.0 million in 2025, then surged by 620.0% to $26.0 million in 2026.
• The last three Operating Income figures came in at $26.0 million (Q1 2026), -$5.0 million (Q4 2025), and $81.0 million (Q3 2025), per Business Quant data.

Peer Comparison